ASMB logo

ASMB

Assembly Biosciences Inc.

$24.70
-$0.80(-3.14%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
$196.56M
Volume
122.38K
52W Range
$7.75 - $27.17
Target Price
$31.67
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
----$9.0M$14.8M$16.0M$79.1M$6.3M$153.0K$7.2M$28.5M
Total Revenue
----$9.0M$14.8M$16.0M$79.1M$6.3M$153.0K$7.2M$28.5M
COST OF GOODS SOLD
Cost of Revenue
----$-4.6M--------------
GROSS PROFIT
Gross Profit
----$9.0M----$79.1M$6.3M$153.0K$7.2M$28.5M
OPERATING EXPENSES
Operating Expenses
$-29.7M$-45.3M$-61.2M$-107.5M$-118.7M$143.9M$138.9M$94.1M$71.8M$73.9M
Research & Development
$18.4M$33.1M$44.2M$72.7M$85.8M$106.8M$68.5M$70.0M$48.9M$55.9M
Research Expense
$18.4M$33.1M$44.2M$72.7M$85.8M$106.8M$68.5M$70.0M$48.9M$55.9M
Selling, General & Administrative
$11.3M$12.2M$17.0M$34.8M$32.9M$37.1M$28.8M$24.1M$22.9M$18.0M
General & Administrative Expenses
$11.3M$12.2M$17.0M$34.8M$32.9M$37.1M$28.8M$24.1M$22.9M$18.0M
Salaries & Wages
$-7.9M$-5.0M$-8.6M$-28.5M$-20.6M------$5.1M$3.1M
Depreciation & Amortization
$-65.0K$-80.3K$-219.0K$-600.0K$-500.0K$700.0K$500.0K$500.0K$500.0K--
Depreciation & Amortization
$-65.0K$-80.3K$-219.0K$-600.0K$-500.0K$700.0K$500.0K$500.0K$500.0K--
Other Operating Expenses
------$-107.5M$-118.7M$-747.0K$-663.0K$-672.0K$-575.0K$-711.0K
OPERATING INCOME
Operating income
$-29.7M$-45.3M$-61.2M$-107.5M$-118.7M$-64.8M$-132.7M$-94.1M$-64.6M$-45.4M
EBITDA
$-28.4M$-44.8M$-51.6M$-89.2M$-99.6M$-64.1M$-90.6M$-92.4M$-64.2M$-43.4M
NON-OPERATING ITEMS
Intinc
$1.2M$1.5M$983.0K$3.1M$4.3M$2.6M$302.0K$1.0M$3.5M$5.6M
Net Non-Operating Interest Income/Expense
$1.2M$1.5M$983.0K$3.1M$4.3M$2.6M$302.0K$1.0M$3.5M$5.6M
Gain on Sale of Securities
$-27.0K$-1.1M$-615.0K$231.0K$4.0K----------
Other Income/Expense
$27.0K$1.1M$-8.4M$-14.8M$-16.0M$-37.0M$22.7M--$-2.7M$-28.3M
Other Special Charges
----$9.0M$14.8M$16.0M$37.0M$6.3M--$2.7M$28.3M
SPECIAL ITEMS
Restructring And Mn A Income
--------$-2.1M$3.8M$1.6M$1.1M----
Special Income Charges
--------$2.1M$-3.8M$-41.6M$-1.1M----
Impairment of Capital Assets
------------$41.6M------
PRE-TAX INCOME
EBIT
$-28.5M$-44.9M$-51.9M$-89.7M$-98.4M$-64.8M$-91.0M$-93.1M$-64.6M$-39.8M
Pre-Tax Income
$-28.5M$-44.9M$-51.9M$-89.7M$-98.4M$-62.2M$-132.4M$-93.1M$-61.2M$-39.8M
INCOME TAX
Tax Provision
--$-617.7K$-9.1M$1.1M$-774.0K--$-2.5M--$33.0K$330.0K
NET INCOME
Net Income
$-28.5M$-44.3M$-42.8M$-90.8M$-97.6M$-62.2M$-129.9M$-93.1M$-61.2M$-40.2M
Net Income (Continuing Operations)
$-28.5M$-44.3M$-42.8M$-90.8M$-97.6M$-62.2M$-129.9M$-93.1M$-61.2M$-40.2M
Net Income (Discontinued Operations)
$-28.5M$-44.3M$-42.8M$-90.8M$-97.6M$-62.2M$-129.9M$-93.1M$-61.2M$-40.2M
Net Income (Common Stockholders)
$-28.5M$-44.3M$-42.8M$-90.8M$-97.6M$-62.2M$-129.9M$-93.1M$-61.2M$-40.2M
Normalized Income
------------------$-39.4M
TOTALS
Total Expenses
$-29.7M$-45.3M$61.2M$-107.5M$-118.7M$143.9M$138.9M$94.1M$71.8M$73.9M
SHARE & EPS DATA
Average Shares Outstanding
$15.7M$17.2M$17.8M$22.8M$26.3M$3.0M$3.6M$4.0M$4.6M$6.0M
Average Shares Outstanding (Diluted)
$15.7M$17.2M$17.8M$22.8M$26.2M$3.0M--$4.0M$4.6M$6.0M
Shares Outstanding
$17.2M$17.3M$20.3M$25.5M$32.6M$3.2M$4.0M$4.3M$5.5M$7.5M
Basic EPS
----------$-21$-36$-23.04$-13.38$-6.69
Basic EPS (Continuing Operations)
----------$-21$-36$-23.04$-13.38$-6.69
Diluted EPS
$-1.81$-2.57$-2.41$-3.98$-3.72$-21$-36$-23.04$-13.38$-6.69
Diluted EPS (Continuing Operations)
--------------$-23.04$-13.38$-6.69
OTHER METRICS
Other Gand A
$11.3M$12.2M$17.0M$34.8M$32.9M$37.1M$28.8M$24.1M$22.9M$18.0M
Other Impairment Of Capital Assets
----------$700.0K$29.0M------
Rent And Landing Fees
$11.3M$12.2M$17.0M$34.8M$32.9M----------
Restruct
--------$-2.1M$3.8M$1.6M$1.1M----

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2ASMB$24.70-3.1%122.38K
3
4
5
6

Get Assembly Biosciences Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.